Insider · CIK 0002034346
Arun Swaminathan
Files at COYA (Coya Therapeutics, Inc.). First filing Nov 12, 2024, latest Nov 13, 2024.
In brief
Arun Swaminathan files SEC Form 4 as CEO and director at COYA (Coya Therapeutics, Inc.). Since Nov 12, 2024, Arun Swaminathan has reported 2 open-market buys worth $73k and 0 open-market sells worth $0, the latest filed on Nov 13, 2024.
A track record needs three past buys with six months of prices behind them; Arun Swaminathan has 0, so none is measured yet.
The newest scored trade: bought $37k of COYA on Nov 13, 2024, filed Nov 13, 2024, scored 61 (notable).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
COYA: Coya Therapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 61Notable | Coya Therapeutics, Inc. | $37k 5,000 shares | +100% | - | |
| 54Moderate | Coya Therapeutics, Inc. | $37k 5,000 shares | - | - |
Transactions
Every row this insider has filed, 4 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 22, 2026 | COYA Coya Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +293,983 | $0.00 | $0 | 293,983 | Jan 26, 2026 |
| Jan 9, 2025 | COYA Coya Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +240,964 | $0.00 | $0 | 240,964 | Jan 13, 2025 |
| Nov 13, 2024 | COYA Coya Therapeutics, Inc. | POpen-market purchase Common Stock, par value $0.0001 per share | +5,000 | $7.36 | $37k | 10,000 | Nov 13, 2024 |
| Nov 11, 2024 | COYA Coya Therapeutics, Inc. | POpen-market purchase Common Stock, par value $0.0001 per share | +5,000 | $7.34 | $37k | 5,000 | Nov 12, 2024 |
Questions about Arun Swaminathan
Answered from the filings on this page, as of the latest one.
Is Arun Swaminathan buying or selling?
Not in the last 12 months. Arun Swaminathan's latest open-market trade on SEC Form 4 was bought $37k of COYA on Nov 13, 2024.
How did Arun Swaminathan's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Arun Swaminathan has 0.
Where does Arun Swaminathan file Form 4?
Arun Swaminathan has filed Form 4 at COYA (Coya Therapeutics, Inc.) as Chief Executive Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.